Sherman, S. (2019) “IL-17A Inhibitor Switching – Efficacy of Ixekizumab Following Secukinumab Failure. A Single-center Experience”, Acta Dermato-Venereologica, 99(9), pp. 769–773. doi: 10.2340/00015555-3200.